Background
Tongue squamous cell carcinoma (TSCC) is one of the most common types of oral squamous cell carcinomas (OSCC). TSCC is highly invasive and characterized by early metastasis and poor prognosis [
1‐
4]. Although therapeutic targets of TSCC have been improved, the mortality rates of TSCC patients are still high [
5‐
7].
Regional lymph node metastasis has been known as an adverse prognostic factor of TSCC [
2,
8,
9]. Poorly differentiated cancer is more likely to have cervical metastasis, positive margins after resecting and poor survival [
10]. Histologic risk is another important prognostic predictor in OSCC [
11]. A better comprehension of the connection between certain molecular alterations and histological differentiation may inject fresh blood into studying the mechanisms of tumor occurrence and development, and provide an effective strategy for the diagnosis, treatment and prevention of TSCC.
Retinol (known as Vitamin A) and its metabolic products are necessary for many biochemical reactions and affect epithelial cell proliferation and differentiation [
12]. The biological effects of retinol are primarily mediated by all trans-retinoic acid receptors (RARs) and 9-cis retinoic acid receptors (RXRs) [
13,
14]. Currently, researchers have focused much attention on the roles of retinoic acid binding proteins and cellular retinol binding proteins (CRABPs and CRBPs) in carcinogenesis. Retinoid intracellular transportation and retinoid-induced cellular activities in physiology are under regulation of CRABPs and CRBPs. Among them,CRBP-1 takes an important part in the uptake and subsequent esterification of retinol and improving bioavailability and transcriptional activities. In addition, CRBP-1 plays a vital role in the embryonic development, growth, vision and survival of vertebrates [
15,
16].
Recent studies found that CRBP-1 was down-regulated in certain human cancer tissues, including prostate cancer [
17], breast cancer [
18], endometrial cancer [
19] and ovarian cancer [
20], and that CRBP-1 was up-regulated in lung adenocarcinoma [
15] and laryngeal cancer [
21]. However, few studies focused on the clinicopathological features of CRBP-1 expression levels in human TSCC. Therefore, the goal of our study was to determine whether CRBP-1 influenced tumor progression and overall survival (OS) rates in TSCC patients. To find out the relationship between CRBP-1 and TSCC, qRT-PCR, western blotting and immunohistochemistry were conducted to examine CRBP-1 expression in a batch of human TSCC tissues and the matched non-tumorous tissues. We also carry out some cell experiments to investigate the effects of CRBP-1 on tumor cells’ proliferation and migration.
Methods
Patients and tumor tissue samples
An immunohistochemistry analysis was conducted on tongue tumor specimens collected from 101 patients who were diagnosed with tongue squamous cell carcinoma and had surgical resection between September of 2005 and February of 2009 at the Head and Neck Department of the Sun Yat-sen University Cancer Center. All patients obtained a biopsy before surgery, and the diagnosis of TSCC was confirmed by the Pathology Department of Sun Yat-sen University Cancer Center according to the World Health Organization (WHO) histological criteria. Patients bearing other primary tumors at the same time were excluded in this study. All patients’ clinicopathological records, based on the clinical and pathologic staging system of the American Joint Committee on Cancer (AJCC), were reviewed. Overall survival (OS), defined as the time from the surgery to the date of death or the last follow-up, were used to measure the patients’ prognosis. Detailed information of the 101 patients is shown in Table
1.
Table 1
Clinical characteristic and CRBP-1 express of 101 patient samples of TSCC
Age (years) |
≤45 | 27(26.7) |
> 45 | 74(73.2) |
Gender |
Male | 61(60.4) |
Female | 40(39.6) |
Tumor size (cm) |
≤2 | 73(72.3) |
> 2 | 28(27.7) |
Differentiation status |
Well | 72(71.3) |
Moderate Poor | 24(23.8) |
Poor | 5(4.9) |
T classification classification |
T1 | 73(72.3) |
T2 | 27(26.7) |
T3 | 1(1.0) |
T4 | 0 |
N classification |
N0 | 78(77.2) |
N1 | 10(9.9) |
N2 | 13(12.9) |
N3 | 0 |
M classification |
M0 | 100(99.0) |
M1 | 1(1.0) |
Clinical stage |
I | 63(62.4) |
II | 15(14.8) |
III | 10(9.9) |
IV | 13(12.9) |
Relapse |
Yes | 23(22.8) |
No | 78(77.2) |
Death |
Yes | 27(26.7) |
No | 74(73.3) |
Expression of CRBP-1 |
Low expression | 49(48.5) |
High expression | 52(51.5) |
48 pairs of fresh TSCC tissues and matching adjacent non-tumorous tongue tissues (located more than 1 cm away from the tumor) collected from TSCC patients after resection at the Sun Yat-sen University Cancer Center from 2011 to 2015 were used for qRT-PCR and western blotting analysis.
Database
The Oncomine microarray database (
http://www.oncomine.org) was used to screen CRBP-1 expression in the paired TSCC samples. “CRBP-1” was used as a keyword in the Oncomine search, “Cancer vs. Normal Analysis” was used as the primary filter, and “Tongue squamous cell carcinoma” was chosen as the cancer type. The up-regulated mRNA levels of CRBP-1 were shown in multiple data sets including Talbot’s, Estilo’s and Ye’s datasets. We also screened the gene expression levels in paired head and neck squamous carcinoma (HNSCC) samples (normal vs. carcinoma tissues). The up-regulated mRNA levels of CRBP-1 were shown in multiple datasets including Cromer’s, Peng’s, Toruner’s and Ginos’ data sets. The CRBP-1 expression data were log-transformed, median-centered per array, and the standard deviation (SD) was normalized to one per array.
Cell culture and generation of stably transfected cell lines
The human TSCC cell line CAL-27 was maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fatal bovine serum (FBS). The human TSCC cell lines (SCC-9, SCC-15 and SCC-25) were cultured in a mixture of DMEM (Invitrogen) and Ham’s F12 medium and DMEM supplemented 25 mM Hepes, 100 μg/mL penicillin/streptomycin, 4 mM L-glutamine and 10% FBS (Gibco). Tca8113 was grown in RPMI-1640 (Invitrogen) supplemented with 10% FBS, 15 mM Hepes, 100 μg /mL penicillin and 2.5 μg /mL. The lentiviruses containing CRBP-1 shRNA were bought from GenePharma (Shanghai, China). The transfection was conducted and stable cell lines (CAL-27 or SCC-25 cells) expressing CRBP-1 shRNAs were selected for 2 weeks with 3 μg/ml puromycin. The sequences targeting CRBP-1 were 5′- GTGGATTGAGGGTGATGAA-3′(#1) and 5’-GTCTGTCTCATTGCCTTGT-3′(#2).
Immunohistochemistry (IHC)
IHC was performed to study CRBP-1 expression in TSCC tissues with the same method described above. At first, paraffin-embedded tissue sections were deparaffinized and rehydrated in a series of descending ethanol concentrations. Then, the sections were treated with 3% hydrogen peroxide for 15 min at room temperature and placed in a high-pressure cooker for antigen retrieval. The slides were incubated with rabbit anti-CRBP-1 (1:100; Abcam, U.S.A.) in a humidified chamber at 4 °C overnight, then incubated with an anti-rabbit secondary antibody at 37 °C for 30 min, following by treatment with diaminobenzidine tetrahydrochloride (DAB) and counterstaining with hematoxylin. An isotypic antibody dilution was used for each sample as the negative control under the same experimental conditions.
The CRBP-1 immunostaining results were scored by two independent pathologists based on both percentage and intensity of positively stained tumor cells under double-blind conditions. The percentage of positive cells was scored as follows:“0”(0–5%), “1”(5–25%), “2”(25–50%), “3”(50–75%) and “4”(75–100%). The intensity were scored as follows: “0”(no staining), “1”(weakly staining), “2”(moderately staining) and “3”(strongly staining). The final score was calculated by multiplying the staining intensity score by the positive percentage score. We devided the patients into high or low expression group with the median score. The final score of low expression group was < 8 and the final score of high expression group was ≥8. [
22]
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted from fresh tissues and TSCC cells using a TRIZOL reagent according to the manufacturer’s instructions (Thermo Fischer Scientific, Waltham, MA, U.S.A.). 2 μg of the extracted RNA pretreated with RNase-free DNase were used for the cDNA synthesis primed with random hexamers. The obtained cDNAs were applied to a real-time PCR analysis to evaluate the relative expression levels of CRBP-1 and β-actin (used as an internal control) with the following primers: 5′- CTACAATGAGCTGCGTGTGG -3′ (forward); 5’-AGGTACTCCTCGAAATTCTCGTT-3′ (reverse) for CRBP-1; 5′- CATGTACGTTGCTATCCAGGC -3′(forward); and 5′- CTCCTTAATGTCACGCACGAT -3′(reverse) for β-actin. The quantitative PCR was performed using a Light Cycler real-time quantitative PCR system 480 (Roche, Germany).
Western blotting assay
Both fresh tissues and TSCC cells were homogenized in a RIPA lysis buffer, and the lysates were cleared by centrifugation. The obtained proteins were then transferred to a polyvinylidene difluoride membrane that was incubated with a CRBP-1 primary antibody (1:1000, Abcam, U.S.A.) or β-actin (1:1000, Abcam, U.S.A.) and with 5% skim milk. The membranes were incubated with anti-rabbit IgG or anti-mouse IgG and then visualized by the ECL system (Santa Cruz Biotechnology, Dallas, TX, U.S.A.).
MTT assay
CAL-27 and SCC-25 cells were implanted in 96-well plates with 1500 cells per well after transfection. Cellular proliferation was measured by means of MTT assay at 1, 2, 3, 4, 5 and 6 days, and their absorbance values were measured at 490 nm wavelength with a spectrophotometric plate reader.
Transwell assay
CAL-27 and SCC-25 cells were respectively trypsinized and counted, and then implanted in the top chamber with the matrigel-coated membrane (24-well insert; pore size, 8 μm; BD Biosciences) with 2 × 105 cells per well in medium without serum. Medium supplemented with serum was used as a chemical attractant in the lower chamber. After incubated for 24 h, the cells that had migrated or invaded through the membrane to the lower surface were fixed, stained, and counted under the inverted microscope. Cells were counted for normalization of matrigel invasion activity by counting the siRNA-treated cells by microscopy 24 h after plating the equal number of the cells on culture plates.
Statistical analysis
Data were presented as mean ± SD. The Chi-square test,Student’s t-test and Fisher’s exact test were used for comparisons between groups. The Kaplan-Meier test and cox regression models were used to analyze the survival rates of the TSCC patients. All data were analyzed with SPSS software (version 21; SPSS Inc., Chicago, IL, U.S.A.). A two-sided p value < 0.05 was regarded as statistically significant.
Discussion
CRBP-1, a member of cellular retinol-binding proteins(CRBPs),belongs to the family of fatty acid-binding proteins, which widely expresses in many tissues [
23]. Ghyselinck et al. found that CRBP-1 is essential in liver vitamin A esterification and storage in their study of mice [
24]. Aberrant CRBP-1 expression has been found closely connected with different tumors and affected patient’s prognosis. Some researches discovered that CRBP-1 was downregulated in hepatocellular carcinoma [
25], endometrial carcinoma [
19], ovarian carcinoma [
20] and breast carcinoma [
18]. On the contrary, CRBP-1 was upregulated in astrocytic gliomas [
26], leiomyosarcoma [
27] and lung adenocarcinoma [
15]. Moreover, decreased expression of CRBP-1 was found relevant to shorter survival time in endometrial carcinoma, ovarian carcinoma and breast carcinoma, while increased expression of CRBP-1 was verified to damage survival time in astrocytic gliomas [
26], leiomyosarcoma [
27] and lung adenocarcinoma [
15]. Some reserchers also found that aberrant CRBP-1 expression related to the differentiation status of breast carcinoma [
18], endometrial carcinoma [
19] and larynx carcinoma [
28]. Although CRBP-1 has been found overexpressed in Talbot’s, Estilo’s and Ye’s datasets in TSCC and Cromer’s, Peng’s, Toruner’s and Ginos’ data sets in HNSCC through microarray studies, but no one of them deepened their researches to dig out the relationship between CRBP-1 expression and the prognosis of TSCC patients and the role of CRBP-1 in TSCC cell lines.
In our study, CRBP-1 expression was investigated at transcription and translation levels in matched TSCC specimens by qPT-PCR and western blotting analysis. The mRNA and protein levels of CRBP-1 increased in tumorous tissues compared to those in the matched non-tumorous tissues. Because of individual difference, the expression of CRBP-1 in TSCC tissues and the matched adjacent normal tissues was different. Some tumor tissues with low expression were almost equal to the normal tissues with high expression. But CRBP-1 was significantly overexpressed in TSCC tissues than the adjacent normal tissues compared by the Student’s t-test (p < 0.05). Moreover, the CRBP-1 expression levels in the immunohistochemical analysis increased in 95.5% of the TSCC tissues (85/89), compared with those in the matched adjacent non-tumorous tissues. All of these experimental results confirmed that CRBP-1 was overexpression in TSCC tissues and it was in accordance with the search results from Oncomine.
In the Kaplan-Meier survival analysis, the CRBP-1 expression levels strongly correlated with TSCC patient survival rates. Patients with higher expression levels of CRBP-1 had a markedly decreased survival rate. Consistently, Elena et al. found the same results in lung adenocarcinoma [
15]. Furthermore, we discovered that CRBP-1 expression, together with the differentiation state and clinical state, was an independent risk factor for TSCC patients by the Cox hazard ratio regression analysis.
We also found that CRBP-1 expression is closely connected with the differentiation status, T classification,clinical stage and death. So up-regulation of CRBP-1 expression might play an important role in tumor differentiation and lymph node metastasis. Under normal conditions, CRBP-1 not only regulates intracellular retinol trafficking and bioconversion, but also facilitates its biological functions [
12]. Specifically, retinol can stimulate the proliferation and differentiation of epithelial cell. High expression levels of CRBP-1 in TSCC were correlated with increased CRBP- 1 gene copy numbers and were also parallel to increased tumor grades, suggesting that high expression levels of CRBP-1 reflects a more aggressive and dedifferentiated phenotype of squamous cell carcinoma. These results are consistent with Elena et al.’s study. They found that 62.3% of adenocarcinomas expressed high level of CRBP-1 which associated with increased tumor grade and reduced OS [
15].
We wondered whether CRBP-1 made a great contribution to tumor proliferation and metastasis. To find out the answer, MTT and transwell assay were conducted in CAL-27 and SCC-25 cell lines with CRBP-1 knocked down. The result revealed that the proliferation and invasion of CRBP-1-knockdown cells was significantly inhibited. A recent study got the similar result in which they found significant inhibition of proliferation of A549 cells transfected with CRBP-1comparing to the control group.
We ascertained that CRBP-1 was distinctly upregulated in TSCC tissues and CRBP-1 upregulation was closely contected with reduced survival of TSCC patients. Besides, CRBP-1 expression of TSCC patients was in relation to tumor differentiation and lymph node metastasis. In addition, in vitro studies revealed that knocking down CRBP-1 inhibit the proliferation and invasion of CAL-27 and SCC-25 cell lines. However, further research is necessary to help us clarify the molecular mechanism of CRBP-1 in TSCC. To summarize, our results declare that CRBP-1 can serve as a prognostic biomarker of TSCC and a potential therapeutic target for TSCC treatment.